Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
also triggers mast cell histamine release as an off-target mechanism
Site-specific pegylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effects
CJC 1295 No DAC and Treatment of Growth Hormone Deficiency Researchers may investigate the potential of CJC-1295 No DAC in the treatment of growth hormone deficiency, contributing to advancements in hormonal therapies
Tirzepatide works by enhancing insulin secretion in response to meals and suppressing glucagon release, which typically raises blood sugar levels
US$ 29.50
US$ 27.31
US$ 24.43
US$ 22.90
